A citation-based method for searching scientific literature

Davide Rossi, Valeria Spina, Alessio Bruscaggin, Gianluca Gaidano. Haematologica 2019
Times Cited: 26







List of co-cited articles
113 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.
David M Kurtz, Florian Scherer, Michael C Jin, Joanne Soo, Alexander F M Craig, Mohammad Shahrokh Esfahani, Jacob J Chabon, Henning Stehr, Chih Long Liu, Robert Tibshirani,[...]. J Clin Oncol 2018
156
38

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.
Florian Scherer, David M Kurtz, Aaron M Newman, Henning Stehr, Alexander F M Craig, Mohammad Shahrokh Esfahani, Alexander F Lovejoy, Jacob J Chabon, Daniel M Klass, Chih Long Liu,[...]. Sci Transl Med 2016
226
30

Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study.
Mark Roschewski, Kieron Dunleavy, Stefania Pittaluga, Martin Moorhead, Francois Pepin, Katherine Kong, Margaret Shovlin, Elaine S Jaffe, Louis M Staudt, Catherine Lai,[...]. Lancet Oncol 2015
233
30

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
716
23

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction.
David M Kurtz, Mohammad S Esfahani, Florian Scherer, Joanne Soo, Michael C Jin, Chih Long Liu, Aaron M Newman, Ulrich Dührsen, Andreas Hüttmann, Olivier Casasnovas,[...]. Cell 2019
75
23

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.
David M Kurtz, Michael R Green, Scott V Bratman, Florian Scherer, Chih Long Liu, Christian A Kunder, Kazuhiro Takahashi, Cynthia Glover, Colm Keane, Shingo Kihira,[...]. Blood 2015
178
23

Diffuse large B-cell lymphoma genotyping on the liquid biopsy.
Davide Rossi, Fary Diop, Elisa Spaccarotella, Sara Monti, Manuela Zanni, Silvia Rasi, Clara Deambrogi, Valeria Spina, Alessio Bruscaggin, Chiara Favini,[...]. Blood 2017
113
23

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, Jaegil Kim, Atanas Kamburov, Robert A Redd, Mike S Lawrence, Margaretha G M Roemer, Amy J Li, Marita Ziepert,[...]. Nat Med 2018
616
19

Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
Valeria Spina, Alessio Bruscaggin, Annarosa Cuccaro, Maurizio Martini, Martina Di Trani, Gabriela Forestieri, Martina Manzoni, Adalgisa Condoluci, Alberto Arribas, Lodovico Terzi-Di-Bergamo,[...]. Blood 2018
112
19

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.
Aaron M Newman, Scott V Bratman, Jacqueline To, Jacob F Wynne, Neville C W Eclov, Leslie A Modlin, Chih Long Liu, Joel W Neal, Heather A Wakelee, Robert E Merritt,[...]. Nat Med 2014
15

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000
15

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Steven H Swerdlow, Elias Campo, Stefano A Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Michele Ghielmini, Gilles A Salles, Andrew D Zelenetz,[...]. Blood 2016
15

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.
Mark Roschewski, Louis M Staudt, Wyndham H Wilson. Blood 2016
46
15

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.
Wyndham H Wilson, Ryan M Young, Roland Schmitz, Yandan Yang, Stefania Pittaluga, George Wright, Chih-Jian Lih, P Mickey Williams, Arthur L Shaffer, John Gerecitano,[...]. Nat Med 2015
658
15

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.
Anas Younes, Laurie H Sehn, Peter Johnson, Pier Luigi Zinzani, Xiaonan Hong, Jun Zhu, Caterina Patti, David Belada, Olga Samoilova, Cheolwon Suh,[...]. J Clin Oncol 2019
183
15

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, Lazaros J Lekakis, David B Miklos, Caron A Jacobson, Ira Braunschweig, Olalekan O Oluwole, Tanya Siddiqi, Yi Lin,[...]. N Engl J Med 2017
15

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Stephen J Schuster, Michael R Bishop, Constantine S Tam, Edmund K Waller, Peter Borchmann, Joseph P McGuirk, Ulrich Jäger, Samantha Jaglowski, Charalambos Andreadis, Jason R Westin,[...]. N Engl J Med 2019
15

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Bertrand Coiffier, Eric Lepage, Josette Briere, Raoul Herbrecht, Hervé Tilly, Reda Bouabdallah, Pierre Morel, Eric Van Den Neste, Gilles Salles, Philippe Gaulard,[...]. N Engl J Med 2002
15

Genetics of diffuse large B-cell lymphoma.
Laura Pasqualucci, Riccardo Dalla-Favera. Blood 2018
98
15

Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas.
S Hohaus, M Giachelia, G Massini, G Mansueto, B Vannata, V Bozzoli, M Criscuolo, F D'Alò, M Martini, L M Larocca,[...]. Ann Oncol 2009
78
11

Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort.
Elodie Bohers, Pierre-Julien Viailly, Stéphanie Becker, Vinciane Marchand, Philippe Ruminy, Catherine Maingonnat, Philippe Bertrand, Pascaline Etancelin, Jean-Michel Picquenot, Vincent Camus,[...]. Blood Cancer J 2018
43
11

Liquid biopsy in non-Hodgkin's lymphoma.
Christopher Melani, Wyndham H Wilson, Mark Roschewski. Hematol Oncol 2019
10
30

Updates on Circulating Tumor DNA Assessment in Lymphoma.
Justin M Darrah, Alex F Herrera. Curr Hematol Malig Rep 2018
10
30

Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.
Daniela Drandi, Lenka Kubiczkova-Besse, Simone Ferrero, Nadia Dani, Roberto Passera, Barbara Mantoan, Manuela Gambella, Luigia Monitillo, Elona Saraci, Paola Ghione,[...]. J Mol Diagn 2015
84
11

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.
Ryan D Morin, Maria Mendez-Lago, Andrew J Mungall, Rodrigo Goya, Karen L Mungall, Richard D Corbett, Nathalie A Johnson, Tesa M Severson, Readman Chiu, Matthew Field,[...]. Nature 2011
11


Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
Alessandro Pastore, Vindi Jurinovic, Robert Kridel, Eva Hoster, Annette M Staiger, Monika Szczepanowski, Christiane Pott, Nadja Kopp, Mark Murakami, Heike Horn,[...]. Lancet Oncol 2015
318
11

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.
Carla Casulo, Michelle Byrtek, Keith L Dawson, Xiaolei Zhou, Charles M Farber, Christopher R Flowers, John D Hainsworth, Matthew J Maurer, James R Cerhan, Brian K Link,[...]. J Clin Oncol 2015
419
11

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
Bruce D Cheson, Richard I Fisher, Sally F Barrington, Franco Cavalli, Lawrence H Schwartz, Emanuele Zucca, T Andrew Lister. J Clin Oncol 2014
11

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study.
Michael Crump, Sattva S Neelapu, Umar Farooq, Eric Van Den Neste, John Kuruvilla, Jason Westin, Brian K Link, Annette Hay, James R Cerhan, Liting Zhu,[...]. Blood 2017
609
11

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.
Nancy L Bartlett, Wyndham H Wilson, Sin-Ho Jung, Eric D Hsi, Matthew J Maurer, Levi D Pederson, Mei-Yin C Polley, Brandelyn N Pitcher, Bruce D Cheson, Brad S Kahl,[...]. J Clin Oncol 2019
138
11

Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.
Andrew Davies, Thomas E Cummin, Sharon Barrans, Tom Maishman, Christoph Mamot, Urban Novak, Josh Caddy, Louise Stanton, Shamim Kazmi-Stokes, Andrew McMillan,[...]. Lancet Oncol 2019
90
11

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Anupama Reddy, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, Cassandra L Love, Alexander Waldrop, Sirpa Leppa, Annika Pasanen, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg,[...]. Cell 2017
469
11

Integrated digital error suppression for improved detection of circulating tumor DNA.
Aaron M Newman, Alexander F Lovejoy, Daniel M Klass, David M Kurtz, Jacob J Chabon, Florian Scherer, Henning Stehr, Chih Long Liu, Scott V Bratman, Carmen Say,[...]. Nat Biotechnol 2016
534
11

Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma.
Keiichiro Hattori, Mamiko Sakata-Yanagimoto, Yasuhito Suehara, Yasuhisa Yokoyama, Takayasu Kato, Naoki Kurita, Hidekazu Nishikii, Naoshi Obara, Shingo Takano, Eiichi Ishikawa,[...]. Cancer Sci 2018
40
11

Quantification of free circulating DNA as a diagnostic marker in lung cancer.
Gabriella Sozzi, Davide Conte, MariaElena Leon, Rosalia Ciricione, Luca Roz, Cathy Ratcliffe, Elena Roz, Nicola Cirenei, Massimo Bellomi, Giuseppe Pelosi,[...]. J Clin Oncol 2003
422
7

Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies.
Stanislav Volik, Miguel Alcaide, Ryan D Morin, Colin Collins. Mol Cancer Res 2016
169
7

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.
Seok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard, Wee Joo Chng, Soon Thye Lim, Huangming Hong, Yong Park, Kian Meng Chang, Yoshinobu Maeda, Fumihiro Ishida,[...]. Lancet Oncol 2016
187
7


Minimal Residual Disease Assessment in Lymphoma: Methods and Applications.
Alex F Herrera, Philippe Armand. J Clin Oncol 2017
23
8

Liquid biopsies come of age: towards implementation of circulating tumour DNA.
Jonathan C M Wan, Charles Massie, Javier Garcia-Corbacho, Florent Mouliere, James D Brenton, Carlos Caldas, Simon Pacey, Richard Baird, Nitzan Rosenfeld. Nat Rev Cancer 2017
7

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
William W L Choi, Dennis D Weisenburger, Timothy C Greiner, Miguel A Piris, Alison H Banham, Jan Delabie, Rita M Braziel, Huimin Geng, Javeed Iqbal, Georg Lenz,[...]. Clin Cancer Res 2009
464
7

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study.
Zijun Y Xu-Monette, Lin Wu, Carlo Visco, Yu Chuan Tai, Alexander Tzankov, Wei-min Liu, Santiago Montes-Moreno, Karen Dybkaer, April Chiu, Attilio Orazi,[...]. Blood 2012
216
7

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, Randy D Gascoyne, Jan Delabie, German Ott, H Konrad Müller-Hermelink, Elias Campo, Rita M Braziel, Elaine S Jaffe,[...]. Blood 2004
7


Genetics of follicular lymphoma transformation.
Laura Pasqualucci, Hossein Khiabanian, Marco Fangazio, Mansi Vasishtha, Monica Messina, Antony B Holmes, Peter Ouillette, Vladimir Trifonov, Davide Rossi, Fabrizio Tabbò,[...]. Cell Rep 2014
334
7

Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy.
Vindi Jurinovic, Robert Kridel, Annette M Staiger, Monika Szczepanowski, Heike Horn, Martin H Dreyling, Andreas Rosenwald, German Ott, Wolfram Klapper, Andrew D Zelenetz,[...]. Blood 2016
111
7


Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS).
Nina D Wagner-Johnston, Brian K Link, Michelle Byrtek, Keith L Dawson, John Hainsworth, Christopher R Flowers, Jonathan W Friedberg, Nancy L Bartlett. Blood 2015
118
7

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.
Elias Campo, Steven H Swerdlow, Nancy L Harris, Stefano Pileri, Harald Stein, Elaine S Jaffe. Blood 2011
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.